Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma

dc.contributor.author	Czudor Zsófia
dc.contributor.author	Mária Balogh
dc.contributor.author	Péter Bánhegyi
dc.contributor.author	Sándor Boros
dc.contributor.author	Nóra Breza
dc.contributor.author	Sipos Anna
dc.contributor.author	Szokol Bálint
dc.contributor.author	Őrfi László
dc.date.accessioned	2018-04-27T08:36:29Z
dc.date.available	2018-04-27T08:36:29Z
dc.date.issued	2018
dc.identifier	85040125313
dc.identifier.citation	pagination=769-773; journalVolume=28; journalIssueNumber=4; journalTitle=BIOORGANIC & MEDICINAL CHEMISTRY LETTERS;
dc.identifier.uri	http://repo.lib.semmelweis.hu//handle/123456789/5272
dc.identifier.uri	doi:10.1016/j.bmcl.2018.01.002
dc.relation.ispartof	urn:issn:0960-894X
dc.title	Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma
dc.type	Journal Article
dc.date.updated	2018-04-20T16:32:38Z
dc.language.rfc3066	en
dc.identifier.mtmt	3343400
dc.identifier.wos	WOS:000425882800040
dc.identifier.pubmed	29329658
dc.contributor.department	SE/GYTK/Gyógyszerészi Kémiai Intézet
dc.contributor.institution	Semmelweis Egyetem